Impact of COVID-19 on business activities and performance
First written in FY2020. 6 of 13 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.
- FY2024ReframedAnnual report
「More than half of the group’s consolidated subsidiaries are overseas subsidiaries, and the group conducts production and sales activities around the world. These overseas locations and the countries and regions in which the group operates face risks including unforeseen changes in laws and regulations, import, export and foreign investment restrictions, deteriorating public safety, economic sanctions between countries, terrorism, war, infectious diseases and other causes of social and political instability.」
COVID-19 is treated not as a standalone risk item, but as one factor contributing to geopolitical and sociopolitical disruption risks associated with overseas operations. - FY2023SoftenedAnnual report
「Although restrictions on social activities related to COVID-19 have been eased, a resurgence of COVID-19 due to variants or other factors may have a significant impact on operating results, financial position and future performance.」
The Company describes the easing of restrictions on social activities and continues to address the risk of a resurgence due to variants or other factors and maintain its management framework. - FY2023-Q3RestatedAnnual report
「In addition, we will continue to closely monitor developments regarding the impact of the spread of COVID-19 on the Group's business activities.」
The Company reiterates its policy of closely monitoring the impact of COVID-19 on business activities, while stating that there have been no material changes in business and other risks. - FY2023-Q2RestatedAnnual report
「In addition, we will continue to closely monitor developments regarding the impact of the spread of COVID-19 on the Group's business activities.」
The Company states that there have been no material changes in the impact of COVID-19 on business activities and continues to closely monitor developments. - FY2023-Q1RestatedAnnual report
「In addition, we will continue to closely monitor developments regarding the impact of the spread of COVID-19 on the Group's business activities.」
The Company states that there have been no material changes in the impact of COVID-19 on business activities and continues to closely monitor developments. - FY2022RestatedAnnual report
「⑥ Resurgence of COVID-19\nThe COVID-19 pandemic, which has spread globally, is affecting the Group's business activities and, depending on when it ends, may have a significant impact on operating results, financial position and future performance.」
The risk of COVID-19 continues to be disclosed as a standalone item under “resurgence,” with the potential impact on business activities and performance unchanged. - FY2022-Q2RestatedAnnual report
「In addition, we will continue to closely monitor developments regarding the impact of the spread of COVID-19 on the Group's business activities.」
Although stating that there have been no material changes in the impact of COVID-19 on business activities, the Company continues to closely monitor developments. - FY2022-Q1RestatedAnnual report
「In addition, we will continue to closely monitor developments regarding the impact of the spread of COVID-19 on the Group's business activities.」
The Company continues to closely monitor developments regarding the impact of COVID-19 on business activities. It states that there have been no material changes in business and other risks. - FY2021MaterialisedAnnual report
「In the business environment surrounding the Group, automobile production, which had declined due to measures to prevent the spread of COVID-19, gradually recovered but had not reached a full recovery, and film and sheet products generally experienced lower sales volumes. Meanwhile, electronic materials related to expanded teleworking and the spread of 5G remained firm.」
The impact of COVID-19 continued to be reflected throughout the fiscal year in delayed recovery of automobile production and lower sales of film and sheet products, while electronic materials related to teleworking and 5G remained firm. - FY2021-Q3MaterialisedAnnual report
「In the business environment surrounding the Group, automobile production, which had declined due to measures to prevent the spread of COVID-19, gradually recovered but had not reached a full recovery, and film and sheet products generally experienced lower sales volumes. Meanwhile, pharmaceutical-related functional chemicals, including those for COVID-19 PCR test kits, and electronic materials related to expanded teleworking and the spread of 5G remained firm.」
The impact of the pandemic continued to be reflected in delayed recovery of automobile production and lower sales of film and sheet products. Meanwhile, demand remained firm for pharmaceutical-related products for PCR test kits and electronic materials related to teleworking and 5G. - FY2021-Q2MaterialisedAnnual report
「In the business environment surrounding the Group, film and sheet products generally experienced lower sales volumes, partly because automobile production declined due to measures to prevent the spread of COVID-19. Meanwhile, functional chemicals for pharmaceutical applications, including COVID-19 PCR test kits, and electronic materials related to expanded teleworking and the spread of 5G remained firm.」
The impact of COVID-19 continued to be reflected in lower automobile production and lower sales of film and sheet products, while demand for functional chemicals for PCR test kits and electronic materials related to teleworking and 5G remained firm. - FY2021-Q1MaterialisedAnnual report
「In the business environment surrounding the Group, film and sheet products generally experienced lower sales volumes, partly because automobile and motorcycle production declined due to measures to prevent the spread of COVID-19. Meanwhile, pharmaceutical-related products, including those for COVID-19 test kits, and electronic materials benefited from firm demand for tablets and other devices against the backdrop of expanded teleworking.」
The impact of COVID-19 was reflected in lower automobile and motorcycle production and lower sales of film and sheet products, while demand increased for pharmaceutical-related products for test kits and tablets for teleworking. - FY2020MaterialisedAnnual report
「The COVID-19 pandemic, which has spread globally, is affecting the Group's business activities and, depending on when it ends, may have a significant impact on operating results, financial position and future performance.」
The impact of COVID-19 on the Group's business activities was disclosed for the first time as a standalone risk item.